» Articles » PMID: 17659658

Redox-dependent Formation of Disulfide Bonds in Human Replication Protein A

Overview
Specialty Chemistry
Date 2007 Jul 31
PMID 17659658
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Human replication protein A (RPA) is a single-stranded DNA (ssDNA)-binding protein with three subunits. The largest subunit, p70, contains a conserved (cysteine)(4)-type zinc-finger motif that has been implicated in the regulation of DNA replication and repair. Previous studies indicated that the ssDNA-binding activity of RPA could be redox-regulated via reversible oxidation of cysteines in the zinc-finger motif. We exposed recombinant human RPA to hydrogen peroxide and characterized the oxidized protein by liquid chromatography/tandem mass spectrometric (LC/MS/MS) analyses. Our results demonstrated that, upon H(2)O(2) treatment, four cysteines, which reside at the zinc-finger motif of the p70 subunit, could result in the formation of two pairs of intramolecular disulfides, Cys481-Cys486 and Cys500-Cys503; no cysteine sulfinic acid or cysteine sulfonic acid could be found. Moreover, the other 11 cysteines in this protein remained intact. The results demonstrated that the formation of disulfide bonds at the zinc-finger site was responsible for the redox regulation of the DNA-binding activity of RPA.

Citing Articles

The iron-sulphur cluster in human DNA2 is required for all biochemical activities of DNA2.

Mariotti L, Wild S, Brunoldi G, Piceni A, Ceppi I, Kummer S Commun Biol. 2020; 3(1):322.

PMID: 32576938 PMC: 7311471. DOI: 10.1038/s42003-020-1048-4.


A new perspective on oxidation of DNA repair proteins and cancer.

Alnajjar K, Sweasy J DNA Repair (Amst). 2019; 76:60-69.

PMID: 30818170 PMC: 6419097. DOI: 10.1016/j.dnarep.2019.02.006.


Roles of UVA radiation and DNA damage responses in melanoma pathogenesis.

Khan A, Travers J, Kemp M Environ Mol Mutagen. 2018; 59(5):438-460.

PMID: 29466611 PMC: 6031472. DOI: 10.1002/em.22176.


Oxidative Stress-Induced Protein Damage Inhibits DNA Repair and Determines Mutation Risk and Therapeutic Efficacy.

McAdam E, Brem R, Karran P Mol Cancer Res. 2016; 14(7):612-22.

PMID: 27106867 PMC: 4955916. DOI: 10.1158/1541-7786.MCR-16-0053.


Cancer drug resistance: redox resetting renders a way.

Liu Y, Li Q, Zhou L, Xie N, Nice E, Zhang H Oncotarget. 2016; 7(27):42740-42761.

PMID: 27057637 PMC: 5173169. DOI: 10.18632/oncotarget.8600.